[Conference Invitation] Weiboxin Invites You to the 33rd Guangdong Animal Husbandry and Veterinary Science and Technology Conference

Conference Theme: Technological Innovation Drives Upgrading and Boosts New-Generation Productive Forces

Meeting Dates: June 27–28

Meeting Location: Guangzhou, Guangdong Province

Conference Size: 800 attendees

Gold-Level Co-Organizer: Guangzhou Weiboxin Biotechnology Co., Ltd.

Conference address location, click to view

Guangzhou Weiboxin Biotechnology, as a manufacturer of diagnostic reagents for animal infectious diseases, operates GMP-compliant production facilities for both enzyme-linked immunosorbent assay–based and molecular biology–based diagnostic products (Class B), and has established two separate production lines for these product categories.

Recently, we have received one happy announcement after another—double good news! We have successfully obtained two certifications and been honored with: Porcine Reproductive and Respiratory Syndrome Virus ELISA Antibody Detection Kit (Veterinary Drug Registration No. 191438213) and Classical Swine Fever Virus Blocking ELISA Antibody Detection Kit (Veterinary Drug Registration No. 191438875) Veterinary drug product approval number.

We cordially invite all partners to attend this conference and visit the Weiboxin booth to exchange ideas, learn from one another, and explore opportunities for collaboration.

Guangzhou Weiboxin Biotechnology Co., Ltd., as a gold-level co-organizer of this year’s Science and Technology Conference, It holds a prominent position and significant influence within the industry.

The company’s core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, and has established a nationwide distribution network. The company primarily manufactures over 100 types of veterinary diagnostic reagents, including those for porcine blue ear disease, avian influenza, Newcastle disease, peste des petits ruminants, foot-and-mouth disease, brucellosis, and lumpy skin disease in cattle.

Our products are widely used by animal disease prevention and control centers at all levels nationwide, customs authorities, livestock farming enterprises, food processing companies, third-party testing laboratories, research institutes, and other organizations.

June 27

Check-in

Morning of June 27

☞ Closed-Door Seminar on Cost Control in Hog Production (Invitation Only)

June 27 – Afternoon

Opening Ceremony Plenary Report

June 28 – Sub-forums

☞Swine Disease Sub-forum

☞Poultry Industry Sub-forum

☞ Livestock and Poultry Genetic Breeding Sub-forum

☞Chinese Veterinary Medicine Sub-forum

☞Animal Nutrition and Feed Sub-forum

☞Pigeon Industry Forum

When looking for animal disease testing reagents, choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City—and is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. The company is also recognized as a “Contract-Honoring and Credit-Keeping Enterprise” in Guangdong Province and a provincial demonstration unit for intellectual property, as well as a industry–university–research collaboration base of Guangdong Food and Drug Vocational College and an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. It has been designated by multiple research institutes, including the Entrepreneurship College of Jinan University in Guangdong Province, as an innovative enterprise with strong growth potential. Furthermore, it has been rated as a “Specialized, Refined, Distinctive, and Innovative” enterprise at both the municipal and provincial levels, receiving awards such as the “Most Investment-Valuable Enterprise” and the title of “Annual African Swine Fever and Porcine Disease Testing Service Provider.” The company has also obtained approval numbers from the Ministry of Agriculture and Rural Affairs for its veterinary drug products: Veterinary Drug Registration No. 191438923 (African Swine Fever Virus Fluorescent PCR Diagnostic Kit), Veterinary Drug Registration No. 191438213 (Reproductive and Respiratory Syndrome Virus ELISA Antibody Detection Kit), and Veterinary Drug Registration No. 191438875 (Classical Swine Fever Virus Blocking ELISA Antibody Detection Kit). In the 11th China Innovation and Entrepreneurship Competition, the company won the Excellence Award in the Growth Category of the Biopharmaceutical Industry; in the Nanotechnology Industry Technology Competition under the same event, it secured the Provincial Second Prize in the Growth Category; and in the National Finals of the Nanotechnology Industry Technology Innovation Special Competition within the China Innovation and Entrepreneurship Competition, it was awarded the National Third Prize in the Growth Category. The company has consecutively received the A-level Tax Credit Honor Certificate, the Four-Star Trademark Brand Certification, and the Two-Integration Management System Assessment Certificate each year. Additionally, it holds ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, along with more than ten trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control fluorescent PCR test kits, clinical and research-grade fluorescent quantitative PCR kits, and transgenic identification test kits (ZL2006). The company has also established a nationwide distribution network covering over ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline, and innovation is our soul; we will unwaveringly uphold this philosophy as we strive to become the premier supplier of rapid diagnostic reagents and instruments.